Items where authors include "Blazeby, J"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Velikova, G orcid.org/0000-0003-1899-5942, Absolom, K orcid.org/0000-0002-5477-6643, Hewison, J orcid.org/0000-0003-3026-3250 et al. (20 more authors) (2022) Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs. Programme Grants for Applied Research, 10 (1). pp. 1-110. ISSN 2050-4322

Calvert, M, King, M, Mercieca-Bebber, R et al. (43 more authors) (2021) SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open, 11 (6). e045105. ISSN 2044-6055

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

McNair, AGK, Whistance, RN, Main, B et al. (20 more authors) (2019) Development of a core information set for colorectal cancer surgery: a consensus study. BMJ Open, 9 (11). e028623-e028623. ISSN 2044-6055

Smyth, EC, Rowley, S, Cafferty, FH et al. (17 more authors) (2019) Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial. JAMA Oncology, 5 (8). pp. 1181-1187. ISSN 2374-2437

Smyth, E, Rowley, S, Allum, W et al. (17 more authors) (2016) A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948). Annals of Oncology, 27 (suppl_6). LBA26. ISSN 0923-7534

Efficace, F, Jacobs, M, Pusic, A et al. (6 more authors) (2014) Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-making. European journal of cancer, 50 (11). 1925 - 1941. ISSN 0959-8049

Proceedings Paper

Gilbert, AJ, O'Connell Francischetto, E, Blazeby, J et al. (4 more authors) (2015) Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach. In: The Lancet. Academy of Medical Sciences: Spring Meeting for Clinician Scientisits in Training, 25 Feb 2015, Royal College of Physicians, London. Elsevier , 38 - 38.